Rosa Diabetes PhysioPD™ Collaboration with Pfizer to be Presented at World PK/PD Summit

Rosa today announced that results from its Diabetes PhysioPD™ collaboration with Pfizer will be presented at the Biorbis World PK/PD Summit in Cambridge, MA April 26-29, 2011. The Diabetes PhysioPD™ model was used to predict long-term clinical outcomes and select doses using only summary pharmacokinetic data from a competitor’s short-term Phase I clinical trial (Press Release).